SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

10.00p
   
  • Change Today:
    -0.75p
  • 52 Week High: 26.10
  • 52 Week Low: 5.20
  • Currency: UK Pounds
  • Shares Issued: 259.04m
  • Volume: 1,647,979
  • Market Cap: £25.90m
  • Beta: 0.01

Latest ShareCast News

Skinbiotherapeutics brings in new audit chair, launches forensic review

By Iain Gilbert

Date: Friday 20 Feb 2026

(Sharecast News) - Life science business SkinBioTherapeutics said on Friday that it has appointed Alyson Levett as a new non‑executive director and chair of the audit committee, with responsibility for overseeing the ongoing investigation into the conduct of its former chief executive and the validity of royalty income booked in its FY25 accounts.

SBTX Regulatory News

Appointment of the Interim CEO to the Board 09-Mar-2026 07:00 RNS
Appointment of Interim CEO 02-Mar-2026 07:00 RNS
Independent Investigation Appointment 20-Feb-2026 07:00 RNS
Update on Board Investigation 16-Feb-2026 07:00 RNS
Resignation of CEO 13-Feb-2026 07:00 RNS

SBTX Tips & Analysis

No recent information was found.

SBTX News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 10.00p
Change Today -0.75p
% Change -6.98 %
52 Week High 26.10
52 Week Low 5.20
Volume 1,647,979
Shares Issued 259.04m
Market Cap £25.90m
Beta 0.01

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average71.12% below the market average
75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average
Price Trend
36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average36.07% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Income Not Available
Growth
49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average49.92% above the market average
72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average72.41% above the sector average

SBTX Dividends

No dividends found

Trades for 12-Mar-2026

Time Volume / Share Price
16:30 18,000 @ 10.24p
15:26 19,481 @ 9.50p
15:26 20,000 @ 9.50p
15:26 30,000 @ 10.00p
15:16 5,000 @ 10.00p

SBTX Key Personnel

CEO Stuart Ashman
CFO Emily Bertram

Top of Page